Cargando…

Analysis of the Neutralizing Activity of Antibodies Targeting Open or Closed SARS-CoV-2 Spike Protein Conformations

SARS-CoV-2 infection elicits a polyclonal neutralizing antibody (nAb) response that primarily targets the spike protein, but it is still unclear which nAbs are immunodominant and what distinguishes them from subdominant nAbs. This information would however be crucial to predict the evolutionary traj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cia, Gabriel, Pucci, Fabrizio, Rooman, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876721/ https://www.ncbi.nlm.nih.gov/pubmed/35216194 http://dx.doi.org/10.3390/ijms23042078

Ejemplares similares

Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro
por: Pucci, Fabrizio, et al.
Publicado: (2021)

Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System
por: Pucci, Fabrizio, et al.
Publicado: (2020)

SARS-CoV-2 spike conformation determines plasma neutralizing activity
por: Bowen, John E., et al.
Publicado: (2021)

pyScoMotif: discovery of similar 3D structural motifs across proteins
por: Cia, Gabriel, et al.
Publicado: (2023)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
por: Xiaojie, Shi, et al.
Publicado: (2021)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants
por: Kim, Ji Woong, et al.
Publicado: (2023)

Distant residues modulate conformational opening in SARS-CoV-2 spike protein
por: Ray, Dhiman, et al.
Publicado: (2021)

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
por: Claireaux, Mathieu, et al.
Publicado: (2022)

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
por: Li, Ruofan, et al.
Publicado: (2022)

An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation
por: Schoof, Michael, et al.
Publicado: (2020)

SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses
por: Carnell, George W., et al.
Publicado: (2021)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)

Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
por: Alenquer, Marta, et al.
Publicado: (2021)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

Computational modeling of protein conformational changes - Application to the opening SARS-CoV-2 spike
por: Kucherova, Anna, et al.
Publicado: (2021)

Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Controlling the SARS-CoV-2 spike glycoprotein conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Stabilizing the closed SARS-CoV-2 spike trimer
por: Juraszek, Jarek, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
por: Huo, Jiandong, et al.
Publicado: (2020)

The effect of spike mutations on SARS-CoV-2 neutralization
por: Rees-Spear, Chloe, et al.
Publicado: (2021)

Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein
por: Zhong, Lilin, et al.
Publicado: (2009)

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
por: Liu, Zhuoming, et al.
Publicado: (2021)

The SARS-CoV-2 Spike variant D614G favors an open conformational state
por: Mansbach, Rachael A., et al.
Publicado: (2021)

SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy
por: Yang, Ziwei, et al.
Publicado: (2022)

The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State
por: Mansbach, Rachael A., et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function
por: Luzak, Boguslawa, et al.
Publicado: (2023)

Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
por: Furukawa, Hiroshi, et al.
Publicado: (2022)

Distinct conformational states of SARS-CoV-2 spike protein
por: Cai, Yongfei, et al.
Publicado: (2020)

Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike
por: Díaz-Salinas, Marco A, et al.
Publicado: (2022)

Conformational stability of SARS-CoV-2 glycoprotein spike variants
por: Arruda, Hiam R.S., et al.
Publicado: (2022)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

Extracellular vesicles carry SARS‐CoV‐2 spike protein and serve as decoys for neutralizing antibodies
por: Troyer, Zach, et al.
Publicado: (2021)

Spike Antibody Assays Can Screen For Viral Neutralizing Activity Toward SARS-CoV-2
por: Schuler, Charles, et al.
Publicado: (2022)

Recombinant subunits of SARS‐CoV‐2 spike protein as vaccine candidates to elicit neutralizing antibodies
por: Noorabad Ghahroodi, Faezeh, et al.
Publicado: (2022)

The SARS-CoV-2 spike protein reversibly samples an open-trimer conformation exposing novel epitopes
por: Shoemaker, Sophie R., et al.
Publicado: (2022)

Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes
por: Gattinger, Pia, et al.
Publicado: (2021)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
por: Kuramochi, Taichi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6aurnq4j6qu4aulv3jrf88imb7